Zoetis Inc. (BIT:1ZTS)

Italy flag Italy · Delayed Price · Currency is EUR
130.40
-2.50 (-1.88%)
At close: Sep 2, 2025
-1.88%
Market Cap58.33B
Revenue (ttm)7.99B
Net Income (ttm)2.22B
Shares Outn/a
EPS (ttm)4.95
PE Ratio26.23
Forward PE23.44
Dividend1.33 (1.02%)
Ex-Dividend DateApr 18, 2025
Volume3
Average Volume62
Open134.00
Previous Close132.90
Day's Range130.40 - 134.00
52-Week Range125.66 - 185.04
Betan/a
RSI49.11
Earnings DateNov 3, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 13,800
Stock Exchange Borsa Italiana
Ticker Symbol 1ZTS
Full Company Profile

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD Financial Statements

News

There is no news available yet.